GoodRx Holdings Revenue 2019-2023 | GDRX
GoodRx Holdings revenue from 2019 to 2023. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
| GoodRx Holdings Annual Revenue (Millions of US $) |
|
|---|---|
| 2023 | $750 |
| 2022 | $767 |
| 2021 | $745 |
| 2020 | $551 |
| 2019 | $388 |
| 2018 | $250 |
| GoodRx Holdings Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2023-12-31 | $197 |
| 2023-09-30 | $180 |
| 2023-06-30 | $190 |
| 2023-03-31 | $184 |
| 2022-12-31 | $184 |
| 2022-09-30 | $187 |
| 2022-06-30 | $192 |
| 2022-03-31 | $203 |
| 2021-12-31 | $213 |
| 2021-09-30 | $195 |
| 2021-06-30 | $177 |
| 2021-03-31 | $160 |
| 2020-12-31 | $154 |
| 2020-09-30 | $140 |
| 2020-06-30 | $123 |
| 2020-03-31 | $133 |
| 2019-12-31 | |
| 2019-09-30 | $102 |
| 2018-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $2.627B | $0.750B |
| GoodRx Holdings Inc. provides consumer-focused digital healthcare platform. GoodRx Holdings Inc. is based in Santa Monica, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $124.258B | 15.59 |
| Cencora (COR) | United States | $44.266B | 17.26 |
| ICON (ICLR) | Ireland | $26.033B | 24.58 |
| DiDi Global (DIDIY) | China | $23.379B | 0.00 |
| Avantor (AVTR) | United States | $17.056B | 25.11 |
| CochLear (CHEOY) | Australia | $14.191B | 0.00 |
| Viatris (VTRS) | United States | $13.264B | 3.96 |
| Revvity (RVTY) | United States | $13.145B | 23.06 |
| Natera (NTRA) | United States | $12.958B | 0.00 |
| Medpace Holdings (MEDP) | United States | $12.348B | 40.62 |
| Charles River Laboratories (CRL) | United States | $11.993B | 22.96 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $11.923B | 0.00 |
| Solventum (SOLV) | United States | $11.243B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $8.782B | 0.00 |
| HealthEquity (HQY) | United States | $6.591B | 49.24 |
| Organon (OGN) | United States | $5.491B | 5.21 |
| Bausch + Lomb (BLCO) | Canada | $5.234B | 20.97 |
| Doximity (DOCS) | United States | $4.386B | 32.65 |
| PACS (PACS) | United States | $4.041B | 0.00 |
| Surgery Partners (SGRY) | United States | $3.426B | 31.35 |
| Sotera Health (SHC) | United States | $3.227B | 15.83 |
| Life Times (LTH) | United States | $2.939B | 30.79 |
| Progyny (PGNY) | United States | $2.617B | 45.05 |
| AMN Healthcare Services Inc (AMN) | United States | $2.370B | 9.39 |
| Premier (PINC) | United States | $2.365B | 8.85 |
| Agilon Health (AGL) | United States | $2.262B | 0.00 |
| NovoCure (NVCR) | Jersey | $2.187B | 0.00 |
| Teladoc Health (TDOC) | United States | $2.161B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $1.936B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.618B | 0.00 | |
| Alignment Healthcare (ALHC) | United States | $1.338B | 0.00 |
| Embecta (EMBC) | United States | $0.842B | 5.73 |
| CareDx (CDNA) | United States | $0.794B | 0.00 |
| Pediatrix Medical (MD) | United States | $0.714B | 7.57 |
| QDM (QDMI) | Hong Kong, SAR China | $0.703B | 18.40 |
| Auna S.A (AUNA) | Luxembourg | $0.639B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.559B | 0.00 |
| GeneDx Holdings (WGS) | United States | $0.558B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.547B | 0.00 |
| Enhabit (EHAB) | United States | $0.453B | 45.20 |
| Sonida Senior Living (SNDA) | United States | $0.451B | 0.00 |
| LifeMD (LFMD) | United States | $0.384B | 0.00 |
| ModivCare (MODV) | United States | $0.384B | 7.18 |
| MultiPlan (MPLN) | United States | $0.364B | 0.00 |
| Beauty Health (SKIN) | United States | $0.346B | 0.00 |
| DocGo (DCGO) | United States | $0.344B | 18.33 |
| Ascend Wellness Holdings (AAWH) | United States | $0.281B | 0.00 |
| Sharecare (SHCR) | United States | $0.273B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.271B | 0.00 |
| Biodesix (BDSX) | United States | $0.171B | 0.00 |
| So-Young (SY) | China | $0.126B | 42.33 |
| Pono Capital Two (PTWO) | United States | $0.068B | 0.00 |
| Oncology Institute (TOI) | United States | $0.067B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.051B | 0.00 |
| NeueHealth (NEUE) | United States | $0.050B | 6.77 |
| Nutex Health (NUTX) | United States | $0.035B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.035B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.032B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.029B | 0.00 |
| OncoCyte (OCX) | United States | $0.024B | 0.00 |
| Aesthetic Medical Hldngs Group (AIH) | China | $0.024B | 0.00 |
| DermTech (DMTK) | United States | $0.022B | 0.00 |
| BIMI Holdings (BIMI) | United States | $0.013B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
| TRxADE HEALTH (MEDS) | United States | $0.008B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| XWELL (XWEL) | United States | $0.007B | 0.00 |
| OpGen (OPGN) | United States | $0.006B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.005B | 0.00 |
| Assure Holdings (IONM) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |